Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies. [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of macitentan in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension who previously r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Status: COMPLETED